Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds Love Clorox Company (CLX)?

Page 1 of 2

Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that’s why their assets under management continue to swell). We believe hedge fund sentiment should serve as a crucial tool of an individual investor’s stock selection process, as it may offer great insights of how the brightest minds of the finance industry feel about specific stocks. After all, these people have access to smartest analysts and expensive data/information sources that individual investors can’t match. So should one consider investing in Clorox Company (NYSE:CLX)? The smart money sentiment can provide an answer to this question.

Clorox Company (NYSE:CLX) was in 31 hedge funds’ portfolios at the end of the third quarter of 2015. Clorox Company (NYSE:CLX) has seen an increase in hedge fund interest lately. There were 27 hedge funds in our database with Clorox Company (NYSE:CLX) holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Apache Corporation (NYSE:APA), Essex Property Trust Inc (NYSE:ESS), and Palo Alto Networks Inc (NYSE:PANW) to gather more data points.

Follow Clorox Co (NYSE:CLX)
Trade (NYSE:CLX) Now!

In the eyes of most traders, hedge funds are assumed to be unimportant, old investment tools of yesteryear. While there are over 8000 funds in operation at the moment, Our researchers look at the top tier of this group, about 700 funds. Most estimates calculate that this group of people controls the majority of the hedge fund industry’s total capital, and by observing their first-class stock picks, Insider Monkey has uncovered a number of investment strategies that have historically outstripped Mr. Market. Insider Monkey’s small-cap hedge fund strategy outrun the S&P 500 index by 12 percentage points annually for a decade in their back tests.

With all of this in mind, we’re going to go over the latest action surrounding Clorox Company (NYSE:CLX).

How have hedgies been trading Clorox Company (NYSE:CLX)?

At the end of the third quarter, a total of 31 of the hedge funds tracked by Insider Monkey were bullish on this stock, an increase of 15% from the second quarter. With the smart money’s sentiment swirling, there exists a select group of noteworthy hedge fund managers who were upping their holdings meaningfully (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Cedar Rock Capital, managed by Andy Brown, holds the biggest position in Clorox Company (NYSE:CLX). Cedar Rock Capital has a $361.9 million position in the stock, comprising 9.4% of its 13F portfolio. On Cedar Rock Capital’s heels is Renaissance Technologies, holding a $211.3 million position; the fund has 0.5% of its 13F portfolio invested in the stock. Other professional money managers with similar optimism include Donald Yacktman’s Yacktman Asset Management, Cliff Asness’ AQR Capital Management, and David Harding’s Winton Capital Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!